Solutions Drug Updates Drug News Support Contact Us

 

 

 

 

 

 

 

Paliperidone extended-release tablets

INVEGA

FDA Approval: December 19, 2006
Indication: Schizophrenia
Pharmacology: Benzisoxazole psychotropic (active metabolite of risperidone)
Usual Dose: 6 mg orally once a day in the morning
Contraindications: Hypersensitivity to paliperidone, risperidone or any ingredients
Warnings: Antipsychotics have been associated with an increased risk of cardiovascular events and mortality in elderly patients with dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, dysphagia, and disruption of body temperature regulation

Paliperidone has been associated with increased QTc interval, orthostatic hypotension, syncope, seizures, hyperprolactinemia, somnolence, sedation, priapism, and antiemetic effects

Caution is recommended in patients with recent myocardial infarction, unstable heart disease, or other carvdiovascular disease

Tablets should not be cut, chewed, or crushed

Safety and efficacy have not been established in pediatric patients or patients with severe hepatic impairment

Dose reduction is recommended in patients with renal impairment (CrCl 10 to 50 mL/min)

Mothers should not breastfeed during treatment

Pregnancy Category: C
Side Effects: Common: Akathisia, extrapyramidal disorder

Dose-related: Somnolence, orthostatic hypotension, salivary hypersecretion, akathisia, dystonia, extrapyramidal disorder, hypertonia, Parkinsonism

Drug Interactions: Alcohol

CNS-active drugs

Dopamine agonists

Levodopa

Other drugs that may cause orthostatic hypotension

QT-prolonging drugs




Every effort has been made to ensure that the information provided by Cerner Multum, Inc. (“Multum”) is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and end-users in the United States. Cerner Multum does not warrant that uses outside of the United States are appropriate.
Multum’s drug information does not endorse drugs, diagnose patients or recommend therapy. Multum’s drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve end-users viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. Healthcare practitioners should use their professional judgment in using the information provided. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient.
Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides.
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2006-2007 Cerner Multum, Inc.


 

Home  Products  Client Support